101. Non-reproductive effects of follicle-stimulating hormone in young men
- Author
-
Angel Elenkov, Elin Wirestrand, Agnes Hagsund, Ilpo Huhtaniemi, Yvonne Lundberg Giwercman, and Aleksander Giwercman
- Subjects
Endocrinology ,Reproductive Medicine ,Urology ,Endocrinology, Diabetes and Metabolism - Abstract
Follicle-stimulating hormone FSH (FSH) receptor expression has been reported in many extra-gonadal tissues, raising the question of non-reproductive effects of FSH. Because of increasing usage of FSH in treatment of male infertility, deeper knowledge of possible harmful off-target effects of FSH is warranted.In total 33 healthy young men (mean age 30 yrs) were included in the study. All received a s.c. injection of gonadotropin-releasing hormone (GnRH) antagonist and n = 16 were randomized to 300 IU recombinant FSH (300 IE 3 times/week) for 5 weeks at first visit (V1) whereas n = 17 served as controls. Blood samples were taken at (V1), after 3 weeks (V2) and after 5 weeks (V3), when the study ended. At V2, all subjects received 1000 mg testosterone undecanoate i.m. A standard set of bio- and inflammatory markers were compared between the groups using the Mann-Whitney test adjusted for multiple testing.As compared to controls, the FSH treated men had higher SHBG and albumin concentrations at V2 (p = 0.024 and p = 0.027, respectively), and lower levels of alanine aminotransferase (p = 0.026) and magnesium (p = 0.028) at V3. However, none of the results remained statistically significant after Bonferroni correction (p0.0011).FSH had no significant effects on non-reproductive organs when given in standard therapeutic doses to young men for five weeks.t. Therefore, FSH treatment can be considered safe in otherwise healthy young men, constituting candidates for infertility treatment with FSH. This article is protected by copyright. All rights reserved.
- Published
- 2022